239 related articles for article (PubMed ID: 16200208)
1. Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt.
Kato T; Muraski J; Chen Y; Tsujita Y; Wall J; Glembotski CC; Schaefer E; Beckerle M; Sussman MA
J Clin Invest; 2005 Oct; 115(10):2716-30. PubMed ID: 16200208
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective stimuli mediate phosphoinositide 3-kinase and phosphoinositide dependent kinase 1 nuclear accumulation in cardiomyocytes.
Rubio M; Avitabile D; Fischer K; Emmanuel G; Gude N; Miyamoto S; Mishra S; Schaefer EM; Brown JH; Sussman MA
J Mol Cell Cardiol; 2009 Jul; 47(1):96-103. PubMed ID: 19269295
[TBL] [Abstract][Full Text] [Related]
3. Akt phosphorylation of zyxin mediates its interaction with acinus-S and prevents acinus-triggered chromatin condensation.
Chan CB; Liu X; Tang X; Fu H; Ye K
Cell Death Differ; 2007 Sep; 14(9):1688-99. PubMed ID: 17572661
[TBL] [Abstract][Full Text] [Related]
4. Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes.
Shiraishi I; Melendez J; Ahn Y; Skavdahl M; Murphy E; Welch S; Schaefer E; Walsh K; Rosenzweig A; Torella D; Nurzynska D; Kajstura J; Leri A; Anversa P; Sussman MA
Circ Res; 2004 Apr; 94(7):884-91. PubMed ID: 14988230
[TBL] [Abstract][Full Text] [Related]
5. Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy.
Tsujita Y; Muraski J; Shiraishi I; Kato T; Kajstura J; Anversa P; Sussman MA
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11946-51. PubMed ID: 16882732
[TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide promotes pancreatic islet beta-cell growth and Akt/Foxo1a/cyclin D2 signaling.
You H; Laychock SG
Endocrinology; 2009 Dec; 150(12):5455-65. PubMed ID: 19837876
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes.
Wu CF; Bishopric NH; Pratt RE
J Biol Chem; 1997 Jun; 272(23):14860-6. PubMed ID: 9169455
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway.
Li X; Lan Y; Wang Y; Nie M; Lu Y; Zhao E
Mol Med Rep; 2017 May; 15(5):2574-2582. PubMed ID: 28447738
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic livers.
Kulhanek-Heinze S; Gerbes AL; Gerwig T; Vollmar AM; Kiemer AK
J Hepatol; 2004 Sep; 41(3):414-20. PubMed ID: 15336444
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells.
Suresh Babu S; Wojtowicz A; Freichel M; Birnbaumer L; Hecker M; Cattaruzza M
Sci Signal; 2012 Dec; 5(254):ra91. PubMed ID: 23233529
[TBL] [Abstract][Full Text] [Related]
12. The ANP-cGMP-protein kinase G pathway induces a phagocytic phenotype but decreases inflammatory gene expression in microglial cells.
Borán MS; Baltrons MA; García A
Glia; 2008 Mar; 56(4):394-411. PubMed ID: 18186083
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide inhibits cardiomyocyte hypertrophy through mitogen-activated protein kinase phosphatase-1.
Hayashi D; Kudoh S; Shiojima I; Zou Y; Harada K; Shimoyama M; Imai Y; Monzen K; Yamazaki T; Yazaki Y; Nagai R; Komuro I
Biochem Biophys Res Commun; 2004 Sep; 322(1):310-9. PubMed ID: 15313208
[TBL] [Abstract][Full Text] [Related]
14. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
15. C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling.
Sciarretta S; Marchitti S; Bianchi F; Moyes A; Barbato E; Di Castro S; Stanzione R; Cotugno M; Castello L; Calvieri C; Eberini I; Sadoshima J; Hobbs AJ; Volpe M; Rubattu S
Circ Res; 2013 May; 112(10):1355-64. PubMed ID: 23529183
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide inhibits mineralocorticoid receptor function in rat colonic surface cells.
Schulman G; Lindemeyer R; Barman A; Karnik S; Bastl CP
J Clin Invest; 1996 Jul; 98(1):157-66. PubMed ID: 8690788
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide suppresses Th17 development through regulation of cGMP-dependent protein kinase and PI3K-Akt signaling pathways.
Ma L; Li J; Wang G; Gong S; Zhang L; Li K; Ji X; Liu Y; Chen P; Xiang X
Regul Pept; 2013 Feb; 181():9-16. PubMed ID: 23327998
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
[TBL] [Abstract][Full Text] [Related]
19. FAK-related nonkinase attenuates hypertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes.
Qin J; Liu ZX
Acta Pharmacol Sin; 2006 Sep; 27(9):1159-64. PubMed ID: 16923336
[TBL] [Abstract][Full Text] [Related]
20. PI 3-kinase pathway is responsible for antiapoptotic effects of atrial natriuretic peptide in rat liver transplantation.
Grutzner U; Keller M; Bach M; Kiemer AK; Meissner H; Bilzer M; Zahler S; Gerbes AL; Vollmar AM
World J Gastroenterol; 2006 Feb; 12(7):1049-55. PubMed ID: 16534845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
